|
 |
LoestrinThis page contains recent news articles, when available, and an overview of Loestrin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Loestrin (when available) Norethindrone is a synthetic oral progestin. It is used for contraception or to treat such conditions as secondary amenorrhea, abnormal uterine bleeding, and endometriosis. As an oral contraceptive, norethindrone is available as either a single agent or in combination with an estrogen. For use as an oral contraceptive in the prevention of pregnancy. Mechanism Of Action: Progestins diffuse freely into target cells and bind to the progesterone receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH surge. News Articles on Norethindrone Warner Chilcott: An Undervalued Growth Play - Dec 21, 2009 Warner Chilcott's largest contributor to sales in 2010 is expected to be that of its Loestrin 24 FE drug, which is designed to prevent pregnancy in women. ... Sumfolio.com Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009 - Nov 9, 2009 The primary drivers of the increase in revenue in the quarter were the net sales of LOESTRIN 24 FE and ESTRACE Cream which were partially offset by net ... CNNMoney.com (press release) Biotech/Pharma Docket - Nov 4, 2009 5552394 and 6667050, with Loestrin® covered by the '394 patent and Femcon® covered by the '050 patent. Earlier this year, Warner Chilcott settled litigation ... Patent Docs (blog) Warner drops patent lawsuit against Lupin - Oct 30, 2009 ...covering birth control drugs Loestrin 24 Fe and Femcon Fe, Irleand-based Warner Chilcott has voluntarily dropped ... mydigitalfc.com Warner Chilcott (NASDAQ: WCRZ) 3Q Profit Rise on Leo Pharma - Nov 9, 2009 Revenue rose 9 percent, to $252.8 million from $231.9 million, due to better sales of products including the oral contraceptive Loestrin and the menopause ... TransWorldNews (press release) Warner Chilcott第三å£ç›ˆåˆ©åŠ²å?‡ - Nov 9, 2009 ...å£åº¦è?¥æ”¶å¢žé•¿9%，从上年å?ŒæœŸçš„2.32亿美元增至2.53亿美元，主è¦?得益于å?£æœ?é?¿å•è?¯Loestrin与更年期è?¯ç‰©Estraceç‰äº§å“?销售é¢?的增长。 分æž?师平å?‡é¢„期该公å?¸å½“å£è?¥æ”¶2.55亿 ... 新浪网 FDA set to OK period suppression pill - May 18, 2007 Among the others, Yaz and Loestrin 24 shorten monthly periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four ... USA Today … patent suit over Loestrin 24 Fe.(Loestrin (norethindrone/ethinyl... - Jul 31, 2006 Warner Chilcott says that it has filed suit against Watson Laboratories and Watson Pharmaceuticals in the US District Court for the District of New Jersey ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Warner Chilcott Q1 net loss narrows, raises 2007 view - May 11, 2007 Warner Chilcott said quarterly revenue rose 31 percent to $218.4 million, helped by sales of oral contraceptive Loestrin 24 Fe and skin product Taclonex, ... Reuters Loestrin 1.5/30 (21) Oral : User Ratings covering uses, effectiveness,... - Dec 9, 2008 I HAVE BEEN SPOTTING FOR 2 WEEKS.I FAINTED THE 1ST WEEK I WAS ON IT. NOW DEPRESSION IS SETTING IN. IAM CALLING MY DOCTOR ASAP FOR CHANGE IN RX. ... WebMD US to approve first pill to end periods - May 19, 2007 Among the others, Yaz and Loestrin 24 shorten periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four times a ... WalesOnline Berlex Schering AG sued for infringement of Loestrin 24 Fe patent. - Apr 1, 2006 Warner Chilcott Company, Inc. (Rockaway, NJ) announced that it has filed suit against Berlex Inc. and Schering AG in the United States District Court for ... Free with registration - BIOTECH Patent News - AccessMyLibrary.com Warner Chilcott sees 1Q profit on lower costs, sales boost - May 9, 2008 ...on a mix of lower costs and higher sales of several key drugs, including the contraceptive Loestrin 24 FE and plaque psoriasis medication Taclonex. ... Boston Globe Warner Chilcott issues 2008 outlook - Jan 28, 2008 Warner projects 2008 revenue of $935 million to $945 million, primarily driven by oral contraceptive Loestrin 24 FE, acne drug Doryx, oral contraceptive ... Boston Globe New Oral Contraceptive, Loestrin(R) 24 Fe, Approved By FDA - Feb 21, 2006 Warner Chilcott announced today that the US Food and Drug Administration (FDA) has approved its 24-day oral contraceptive, Loestrin(R) 24 Fe (norethindrone ... Medical News Today - Medical News Today (press release) Loestrin 24 Fe.(drug approval for oral contraceptive)(Brief article) - Apr 1, 2006 Loestrin 24 Fe (norethindrone acetate/ethinyl estradiol and ferrous fumarate) tablets have been approved as a an oral contraceptive regimen for 24 days of ... Free with registration - Patient Care for the Nurse Practitioner - AccessMyLibrary.com Multimedia News Release - National Survey Finds That Women Want … - May 18, 2006 Loestrin 24 Fe, made by Warner Chilcott, is the first oral contraceptive ... Women aged 36 and older who took Loestrin 24 Fe had even shorter periods, ... RedOrbit WARNER CHILCOTT LIMITED at Morgan Stanley Pharmaceutical CEOs … - Jan 4, 2007 Is Femcon the next Loestrin 24? And in our minds that is what we believe. UNIDENTIFIED PARTICIPANT: Can you expand upon that a little bit, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com What type of COC pill you are taking (see section on "Names" for the... - Feb 5, 2008 If you are taking Loestrin 20, Mercilon, Femodette or Sunya 20/75 and you have missed one pill, you do not need to worry. ... NHS Choices Article: Berlex Schering AG sued for infringement of Loestrin 24 Fe... - Apr 1, 2006 Berlex Schering AG sued for infringement of Loestrin 24 Fe patent. ... find BIOTECH Patent News articles. Warner Chilcott Company, Inc. (Rockaway, ... Pay-Per-View - BIOTECH Patent News - HighBeam Research … : Warner Chilcott Sues Watson for Infringement of Loestrin(R) 24 Fe... - Jul 31, 2006 Warner Chilcott Sues Watson for Infringement of Loestrin(R) 24 Fe Patent. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Pills can liberate but also impose new burdens - May 31, 2007 Last year, the drug administration approved Yaz and Loestrin 24, which cut the number of dummy pills to four per cycle. Other devices eliminated periods ... Pay-Per-View - Daily Mercury - ProQuest Archiver Article: Berlex Schering AG sued for infringement of Loestrin 24 Fe... - Mar 1, 2006 Berlex Schering AG sued for infringement of Loestrin 24 Fe patent. ... find BIOTECH Patent News articles. Warner Chilcott Company, Inc. (Rockaway, ... Pay-Per-View - BIOTECH Patent News - HighBeam Research Pharmacists with No Plan B - Aug 1, 2006 He told Renz he could not provide Loestrin. The store's head pharmacist, who knew Noesen's concerns, had agreed to personally fill such prescriptions, ... ChristianityToday.com Q4 2007 WARNER CHILCOTT LIMITED Earnings Conference Call - Final … - Feb 29, 2008 The increases in both periods were led by sales of Loestrin 24 and Taclonex. ... Loestrin 24 ended the year with with a 4.5 share of new prescriptions in ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Warner Chilcott Reports Operating Results for the Quarter Ended June... - Jun 30, 2007 Continued growth driven by Loestrin 24 and Taclonex; Company raises full year 2007 financial ... We began commercial sales of LOESTRIN 24 FE in March 2006. ... prnewswire.com Moody's revises Warner Chilcott outlook. - Oct 9, 2006 ...the recent launch of its Loestrin 24 Fe oral contraceptive, and the parent company's decision to use proceeds from its IPO to pay down debt. ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Warner Chilcott Reports Operating Results for the Quarter and Year … - Mar 7, 2007 ..."Our recently launched products, LOESTRIN 24 FE and TACLONEX, ... LOESTRIN 24 FE has been the top promotional priority of our 175 territory Women's ... $4.95 - PR Newswire - ECNext WARNER CHILCOTT LIMITED at Morgan Stanley Pharmaceutical CEOs … - Jan 4, 2008 I think Loestrin 24, when we look at Loestrin 24 and the execution of Loestrin 24, ... UNIDENTIFIED PARTICIPANT: Let's spend more time on Loestrin 24, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Alford Pomeroy: 'Morning after' pill not exactly the same as birth... - Sep 19, 2006 Most birth control pills, such as Yasmin, Loestrin and the Ortho products, are combination pills, which contain synthetic estrogen and progesterone hormones ... Online Athens Warner Chilcott Reports Operating Results for the Quarter and Year … - Dec 31, 2007 Continued year over year growth driven by Loestrin 24 Fe and Taclonex ST. ... LOESTRIN 24 FE generated revenues of $41.6 million in the quarter ended ... prnewswire.com FINAL TRANSCRIPT - May 9, 2008 ...by the sales of our key promoted products, Loestrin 24, Doryx, Taclonex and Femcon. Loestrin 24 generated revenues of $46.9 ... $54.00 - Thomson StreetEvents - Alacra Store Warner Chilcott Reports Operating Results for the Quarter Ended June... - Aug 10, 2007 We began commercial sales of LOESTRIN 24 FE in March 2006. Beginning in April 2006, LOESTRIN 24 FE became our top promotional priority amongst our oral ... Free with registration - PR Newswire - AccessMyLibrary.com Warner Chilcott Reports Operating Results for the Quarter and Year … - Dec 31, 2006 ..."Our recently launched products, LOESTRIN 24 FE and TACLONEX, ... LOESTRIN 24 FE has been the top promotional priority of our 175 territory Women's ... prnewswire.com Warner Chilcott Reports Results for The Quarter Ended March 31, 2005. - Jun 28, 2005 Adjusted EBITDA for the prior year quarter includes the elimination of profits associated with sales of certain divested LOESTRIN(R) branded oral ... $4.95 - PR Newswire - ECNext Warner Chilcott Reports Operating Results for the Year and the... - Dec 31, 2005 Our hard work in 2005 enabled us to enter 2006 primed to support the launches of TACLONEX(R) and LOESTRIN(R) 24 FE." Revenue For the year ended December 31, ... prnewswire.com Cuatro reglas al año o reglas de tres dÃas - May 24, 2007 Yaz y Loestrin, por ejemplo, reducen a tres los dÃas de sangrado, mientras que otras como Seasonique limitan a cuatro el número de reglas al año. ... Diario Vasco Oral Contraception and Combination Hormonal Methods - Dec 31, 2008 Norethindrone is used in Loestrin and Loestrin 24 Fe (which adds iron supplements to ... Loestrin 24 Fe uses 24 days of active pills followed by 4 days of ... New York Times Ð’ СÐ?Щ одобриха хапче, което Ñ?пира менÑ?труациÑ?та - May 23, 2007 Има нетрадиционни противозачатъчни хапчета, като "Yaz" и "Loestrin 24", които Ñ?къÑ?Ñ?ват меÑ?ечните цикли до 3 или по-малко дни; "Seasonique" ги намалÑ?ва на 4 ... BG Newsroom Warner Chilcott Reports Operating Results for the Quarter Ended … - Nov 9, 2007 We began commercial sales of LOESTRIN 24 FE in March 2006 and launched ... LOESTRIN 24 FE generated revenue of $38.2 million in the quarter ended September ... $4.95 - PR Newswire - ECNext Article: Correction: Dec. 8 Contraceptive Story - AP Online |... - Dec 10, 2006 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Drugmaker Makes Chewable Contraceptive - AP Online | … - Dec 7, 2006 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - Associated Press/AP Online - HighBeam Research New pill puts periods on hold indefinitely - May 23, 2007 Among the others, Yaz and Loestrin 24 shorten monthly periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four ... Pay-Per-View - The Record - ProQuest Archiver Article: Drugmaker Makes Chewable Contraceptive - AP Online | … - Dec 8, 2006 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Stock Market Update, IPO profiles, Earnings Call Transcripts,... - Jun 9, 2006 In March 2003, the Company acquired the oral contraceptives Loestrin and Estrostep, ... By contrast, with Loestrin 24 Fe women take the active pills for 24 ... 123Jump.com Press Release: Barr Confirms Filing an Application With a Paragraph... - Aug 15, 2007 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Warner Chilcott Reports Operating Results for the... - Nov 10, 2008 LOESTRIN 24 FE generated revenue of $50.8 million in the quarter ended September ... The increase in LOESTRIN 24 FE net sales was primarily due to a 22.3% ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Warner Chilcott Reports Operating Results for the... - Nov 9, 2007 Continued year over year growth driven by Loestrin 24 and Taclonex; ... We began commercial sales of LOESTRIN 24 FE in March 2006 and launched promotional ... Pay-Per-View - PR Newswire - HighBeam Research Article: Drugmaker Makes Chewable Contraceptive - AP Online | … - Dec 7, 2006 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Drugmaker Makes Chewable Contraceptive - AP Online | … - Dec 8, 2006 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Drugmaker Makes Chewable Contraceptive - AP Online | … - Dec 7, 2006 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: 1st Chewable Contraceptive on Market - AP Online | HighBeam ... - Dec 7, 2006 LOESTRIN 24 ... which expires in 2014. FEMCON FE, which was introduced ... LOESTRIN 24 FE and FEMCON FE, respectively ... with respect to FEMCON FE during ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Warner Chilcott Reports Operating Results for the Quarter ended March... - Mar 31, 2006 During the quarter we recorded $1.4 million of net sales of LOESTRIN(R) 24 FE representing our initial sales of the product to the channel in preparation ... prnewswire.com Warner Chilcott Reports Results for the Quarter and Nine Months ended... - Sep 30, 2005 Adjusted EBITDA for the nine months ended September 30, 2004 excludes profits associated with sales of certain divested LOESTRIN(R) branded oral ... prnewswire.com Warner Chilcott Reports Operating Results for the Quarter and Six... - Jun 30, 2006 TACLONEX(R) and LOESTRIN(R) 24 FE began commercial sales in March 2006 and together ... Beginning in April 2006, LOESTRIN(R) 24 FE became the Company's top ... prnewswire.com Warner Chilcott Reports Results for the Quarter and Six Months ended ... - Jun 30, 2005 Adjusted EBITDA for the six months ended June 30, 2004 excludes profits associated with sales of certain divested LOESTRIN(R) branded oral contraceptive ... prnewswire.com Health Products Research(R) Reports Key Findings on Pharmaceutical … - Jul 26, 2006 Warner-Chilcott details supporting the launch of Loestrin(R) 24 Fe (#4 promoted OC) ... Not surprisingly, recently launched brands Loestrin(R) 24 Fe (13 ... RedOrbit Warner Chilcott Reports Operating Results for the Quarter ended March... - May 15, 2006 During the quarter we recorded $1.4 million of net sales of LOESTRIN(R) 24 FE representing our initial sales of the product to the channel in preparation ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Warner Chilcott Reports Operating Results for the... - Feb 29, 2008 Continued year over year growth driven by Loestrin 24 Fe and Taclonex. Warner Chilcott Limited (Nasdaq: WCRX) today announced its results for the quarter ... Pay-Per-View - PR Newswire Europe - HighBeam Research More women opt for pill regimens to control menstruation - Jul 27, 2006 Loestrin 24 Fe and Seasonique work in different ways. ... Loestrin 24 Fe's ad campaign, for example, features a carefree young woman whose social life is ... East Valley Tribune St. John's wort may not curb OC effectiveness.(Gynecology)(Brief... - May 15, 2005 They took Loestrin 1/20 for four consecutive 28-day cycles. During the last two cycles, the protocol added 300 mg of St. John's wort taken three times daily ... Free with registration - OB GYN News - AccessMyLibrary.com Press Release: Health Products Research(R) Reports Key Findings on … - Jul 26, 2006 Warner-Chilcott details supporting the launch of Loestrin(R) 24 Fe (#4 promoted OC) ... Not surprisingly, recently launched brands Loestrin(R) 24 Fe (13 ... Pay-Per-View - PR Newswire - HighBeam Research … Schering AG, Maker of Yaz(R), Sued for Infringement of Loestrin(R)... - Mar 27, 2006 Warner Chilcott, through its US affiliate, plans to launch Loestrin(R) 24 Fe in April. "Loestrin(R) 24 Fe embodies a novel new dosing regimen for oral ... $4.95 - PR Newswire - ECNext Warner Chilcott Reports Operating Results for the Year and the... - Mar 29, 2006 Excluding contract manufacturing revenue in both years, and excluding sales of certain divested LOESTRIN(R) products in the prior year, our revenue growth ... $4.95 - PR Newswire - ECNext Press Release: Warner Chilcott Reports Operating Results for the Year... - Mar 29, 2006 Excluding contract manufacturing revenue in both years, and excluding sales of certain divested LOESTRIN(R) products in the prior year, our revenue growth ... Pay-Per-View - PR Newswire - HighBeam Research Warner Chilcott Reports Results for the Quarter and Nine Months ended... - Nov 11, 2005 Adjusted EBITDA for the nine months ended September 30, 2004 excludes profits associated with sales of certain divested LOESTRIN(R) branded oral ... $4.95 - PR Newswire - ECNext Warner Chilcottå°†å?‘è¡Œ13亿美元åˆ?始股 - Sep 6, 2006 Warner Chilcott的主è¦?产å“?包括å?£æœ?é?¿å•è?¯Loestrin 24 Fe和皮肤病è?¯ç‰©Taclonex。 ... 该诉讼æº?自6月23æ—¥Watsonæ??交了为自己生产的一ç§?Loestrin 24 Fe仿制å“?获得快速 ... 新浪网 New Oral Contraceptive Approved By FDA - Feb 17, 2006 Loestrin 24 Fe ("Loestrin 24") is the first birth-control pill approved in the United States that provides 24 days of active hormonal therapy and four days ... RedOrbit Warner Chilcott Announces Receipt of Paragraph IV Certification... - Jun 23, 2006 LOESTRIN 24 FE, which was launched by Warner Chilcott in April 2006, is the newest product in Warner Chilcott's portfolio of oral contraceptives and is ... Free with registration - PR Newswire - AccessMyLibrary.com Warner Receives Patent Challenge On Oral Contraceptive - Jun 29, 2006 According to the AP/MSNBC.com, Warner released Loestrin 24 FE in April and holds a patent that does not expire until 2014. Watson has given Warner notice ... Medical News Today - Medical News Today (press release) Warner Chilcott Reports Operating Results for the Quarter ended … - Nov 14, 2006 The increase was driven by sales of LOESTRIN(R) 24 FE, DOVONEX(R) and TACLONEX(R), ... Beginning in April 2006, LOESTRIN(R) 24 FE became the Company's top ... $4.95 - PR Newswire - ECNext Warner Chilcott Reports Operating Results for the Quarter and Six... - Aug 11, 2006 TACLONEX(R) and LOESTRIN(R) 24 FE began commercial sales in March 2006 and together ... Beginning in April 2006, LOESTRIN(R) 24 FE became the Company's top ... $4.95 - PR Newswire - ECNext New Warner Chilcott posts 1st-qtr loss.(Warner Chilcott Holdings) - Jul 11, 2005 Excluding $6.6 million of non-strategic and low-margin contract manufacturing revenues included in the current quarter and $13.5 million of Loestrin ... $4.95 - Pharma Marketletter - ECNext Now, a birth control bonanza; As safer and more advanced contraceptive... - Jul 10, 2006 The products -- Loestrin 24 Fe and Yaz -- provide 24 days of active pills, forms of the hormones estrogen and progestin, followed by four days of placebo ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Warner Chilcott Reports Results for the Quarter and Six Months ended ... - Aug 16, 2005 Adjusted EBITDA for the six months ended June 30, 2004 excludes profits associated with sales of certain divested LOESTRIN(R) branded oral contraceptive ... $4.95 - PR Newswire - ECNext Press Release: Warner Chilcott Reports Operating Results for the... - May 11, 2007 LOESTRIN 24 FE and TACLONEX Fuel Strong Growth in First Quarter Revenue and Cash Net Income. Warner Chilcott Limited (Nasdaq: WCRX) today announced its ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Barr Announces Warner Chilcott Waives Exclusive … - Sep 26, 2006 PR Newswire; September 10, 2009 ; 700+ words ... ... for infringement of Warner Chilcott's U.S. Patent ... on which another generic version of LOESTRIN 24 ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Warner Chilcott Reports Operating Results for the... - Mar 7, 2007 ..."Our recently launched products, LOESTRIN 24 FE and TACLONEX, ... LOESTRIN 24 FE, FEMCON FE, TACLONEX and ... prescriptions over the prior year quarter and ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Oral Contraceptive Approved by FDA. - PR … - Feb 17, 2006 Loestrin 24 Fe ("Loestrin 24") is the first birth-control pill approved in the United States that provides 24 days of active hormonal therapy and four days ... Pay-Per-View - PR Newswire - HighBeam Research Article: FDA Approves Period Suppression Pill - AP Online | HighBeam ... - May 22, 2007 Some nontraditional pills such as Yaz and Loestrin 24 shorten monthly periods to three days or less. Seasonique, an updated version of Seasonale, ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Press Release: Warner Chilcott Reports Operating Results for the... - May 15, 2006 During the quarter we recorded $1.4 million of net sales of LOESTRIN(R) 24 FE representing our initial sales of the product to the channel in preparation ... Pay-Per-View - PR Newswire - HighBeam Research … Schering AG, Maker of Yaz(R), Sued for Infringement of Loestrin(R)... - Mar 27, 2006 Berlex Inc. and Schering AG, Maker of Yaz(R), Sued for Infringement of Loestrin(R) 24 Fe Patent. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Warner Chilcott Reports Operating Results for the... - Nov 9, 2007 Continued year over year growth driven by Loestrin 24 and Taclonex; Company updates full year 2007 financial guidance. Warner Chilcott Limited (Nasdaq: ... Pay-Per-View - PR Newswire Europe - HighBeam Research Article: St. John's Wort does not mitigate antiandrogenic effects of... - Jul 1, 2005 They took Loestrin 1/20 for four consecutive 28-day cycles. During the last two cycles, the protocol added 300 mg of St. John's wort taken three times daily ... Pay-Per-View - Family Practice News - HighBeam Research St. John's wort may not curb OC effectiveness.(Gynecology)(Brief... - May 15, 2005 They took Loestrin 1/20 for four consecutive 28-day cycles. During the last two cycles, the protocol added 300 mg of St. John's wort taken three times daily ... Pay-Per-View - OB GYN News - HighBeam Research Article: Just say 'OK'.(Column) - Information Today | HighBeam... - Mar 1, 2008 ...significant value and for a fair resolution of outstanding patent ... would acquire from Galen the exclusive rights to manufacture and market Loestrin . ... Pay-Per-View - Information Today - HighBeam Research Press Release: Mohegan Tribal Gaming Authority Announces Second … - May 5, 2005 LOESTRIN ... the quarter ended March 31, 2009, compared to the prior year quarter. ... LOESTRIN ... the quarter ended March 31, 2008, compared to the prior ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Explore Marketing Budgets for 9 Brands Throughout... - Apr 8, 2008 Hormonal Content of ESTROSTEP and Various Other Currently Marketed OCs OC Brand Ethinyl estradiol (mcg) Progestin (mg) LOESTRIN(R) 1/20 20 1 (1 mg ... Pay-Per-View - M2 Presswire - HighBeam Research Suggestion Box Inc acquires Changing Times Vitamins Inc - Aug 21,... - Aug 21, 2008 Participant Let's spend more time on Loestrin ##, because clearly…I would say the second time we went to the well…investment in DTC. ... Pay-Per-View - deals - Alacra Store Partner, director, client services and agency operations, Concentric ... - Aug 1, 2006 The firm recently managed simultaneous launches of campaigns for Cardura XL, Loestrin 24 and Talconex--proving, Begasse says, that they can handle the ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com Advancements in birth control give women more options - Mar 27, 2007 She said two new 24-day, active pill regimens include YAZ and Loestrin 24 Fe, ... YAZ and Loestrin 24 Fe also contain “very low-dose estrogenâ€? and because ... phillyBurbs.com Air Force News, news from Iraq - Air Force Times - Jan 18, 2007 24, oral contraceptives Loestrin 24 Fe and Seasonique will move to “Tier 3,â€? which means they will cost $22 for a 30-day supply through Tricare's mail order ... AirForceTimes.com Product News from 03/03/06 News Brief - Mar 3, 2006 Loestrin 24 is the first birth-control pill approved in the US that provides 24 days of active hormonal therapy and four days of iron-containing placebo ... Medical Marketing & Media - Medical Marketing and Media Data Show Low Incidence Of Breakthrough Bleeding With ORTHO TRI- … - May 10, 2007 Loestrin Fe 1/20 is marketed by Barr Pharmaceuticals, Inc. Serious as well as minor side effects have been reported with the use of oral contraceptives. ... Medical News Today - Medical News Today (press release) Q4 2005 Warner Chilcott PLC Earnings Conference Call - Part 2. - Mar 31, 2006 First of all, Loestrin 24 Fe is produced for us in our facility in Fajardo, ... I mean, actually, we are selling as we speak both Loestrin 24 and Taclonex ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com PulseClinical - CONTRACEPTION UPDATE: COMBINED ORAL … - Mar 8, 2007 ...or gestodene products for risk-factor and migraine-free COC-users above age 35, with the norethisterone option (Loestrin 20) as an alternative. ... Free with registration - Pulse - AccessMyLibrary.com Birth control pill suppresses periods | Article from Oakland Tribune... - May 19, 2007 Among the others, Yaz and Loestrin 24 shorten monthly periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four ... Pay-Per-View - Oakland Tribune - HighBeam Research Article: Birth control pill suppresses periods - Oakland Tribune | … - May 19, 2007 Among the others, Yaz and Loestrin 24 shorten monthly periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four ... Pay-Per-View - Oakland Tribune - HighBeam Research Press Release: Warner Chilcott Reports Operating Results for the... - Feb 29, 2008 Continued year over year growth driven by Loestrin 24 Fe and Taclonex. ST. DAVID'S, Bermuda, Feb. 29 /PRNewswire-FirstCall/ -- Warner Chilcott Limited today ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Warner Chilcott Reports Operating Results for the... - May 9, 2008 The primary drivers of the increase in revenue were the net sales of our promoted products LOESTRIN 24 FE, DORYX, TACLONEX and FEMCON FE, which together ... Pay-Per-View - PR Newswire Europe - HighBeam Research FDA Set to OK Period Suppression Pill | Article from AP Online | … - May 18, 2007 Among the others, Yaz and Loestrin 24 shorten monthly periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Warner Chilcott.(Pipeline) - Medical Marketing & Media | … - Apr 1, 2006 ...find Medical Marketing & Media articles. Warner Chilcott announced that the FDA has approved its 24-day oral contraceptive, Loestrin 24 (norethin-dron... Pay-Per-View - Medical Marketing & Media - HighBeam Research Press Release: Multimedia News Release - National Survey Finds That … - May 18, 2006 Help for these women is at hand in the form of a new birth control pill that is now available: Loestrin(R) 24 Fe (norethindrone acetate and ethinyl ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Cinram Announces Second Quarter Results. - PR … - Aug 10, 2006 LOESTRIN ... the quarter ended June 30, 2009, compared to the prior year quarter. Net ... the quarter ended June 30, 2009, compared to the prior year ... Pay-Per-View - PR Newswire - HighBeam Research Article: FDA Set to OK Period Suppression Pill - AP Online | HighBeam... - May 18, 2007 Among the others, Yaz and Loestrin 24 shorten monthly periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: FDA Set to OK Period Suppression Pill - AP Online | HighBeam... - May 19, 2007 Among the others, Yaz and Loestrin 24 shorten monthly periods to three days or less and Seasonique, an updated version of Seasonale, reduces them to four ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Brand Names/Synonyms: Loestrin is also known by the following brand names and/or synonymsAnhydrohydroxynorprogesterone; Anovulatorio; Anovule; Aygestin; Binovum; Brevicon; Brevinor; Brevinor 21; Brevinor 28; Brevinor-1 21; Brevinor-1 28; CCRIS 484; Camila; Ciclovulan; Conceplan; Conludaf; Conludag; Demulen; ENT; Errin; Estrinor; Ethinylnortestosterone; Ethynylmortestosterone; Ethynylnortestosterone; Gencept; Genora; Gestest; HSDB 3370; Jenest; Jenest-28; Levlen; Loestrin; Menzol; Microneth; Micronett; Micronor; Micronovum; Milli; Mini-Pe; Mini-Pill; Minovlar; Modicon; N.E.E.; NET; NSC-9564; Necon; Nelova; Neocon; Nodiol; Nor-Q.D.; Nor-Qd; Noraethisteronum; Noralutin; Norcept; Norcept-E; Norcolut; Nordette; Noresthisterone; Norethadrone; Norethin; Norethin 1/35 E; Norethin 1/50 M; Norethindrone; Norethindrone Acetate; Norethindrone Norethisterone; Norethisteron; Norethisterone; Norethisterone [Progestins]; Norethisteronum [Inn-Latin]; Norethyndron; Norethynodron; Norethynodrone; Noretisterona [Inn-Spanish]; Noretisterone [Dcit]; Norfor; Norgestin; Noriday; Noriday 28; Norimin; Norinyl; Norlestrin; Norlutate; Norluten; Norlutin; Norluton; Normapause; Norpregneninlone; Norpregneninolone; Norpregneninotone; Orlest; Ortho 1 35; Ortho 7 7 7; Ortho-Novum; Ortho-Novum 1 35; Ortho-Novum 1 50; Ortho-Novum 7 7 7; Ovcon; Ovral; Ovrette; Ovysmen; Ovysmen 0.5 35; Ovysmen 1 35; Palonyl; Perovex; Primolut N; Primolut-N; Proluteasi; SC 4640; Synphase; Synphasic 28; Tri-Levlen; Tri-Norinyl; Triella; Trinovum; Trinovum 21; Utovlan; Utovlar Drug Category: Loestrin is categorized under the following by the FDA: Contraceptives, Oral, Synthetic; Progestins; ATC:G03CA Dosage Forms: TABLET Absorption: Absolute oral bioavailability approximately 64% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |